Last Updated : June 4, 2024
Details
Review Type: Panel
Review Type: Panel
Call for patient/clinician input open | February 08, 2024 |
---|---|
Call for patient/clinician input closed | April 02, 2024 |
Clarification: - Patient input submission received from My Gut Feeling - Stomach Cancer Foundation of Canada | |
Submission received | March 13, 2024 |
Submission accepted | March 28, 2024 |
Review initiated | April 01, 2024 |
Draft CADTH review report(s) provided to sponsor for comment | June 20, 2024 |
Deadline for sponsors comments | July 02, 2024 |
CADTH review report(s) and responses to comments provided to sponsor | August 01, 2024 |
Expert committee meeting (initial) | August 14, 2024 |
Draft recommendation issued to sponsor | August 27, 2024 |
Draft recommendation posted for stakeholder feedback | September 05, 2024 |
End of feedback period | September 19, 2024 |
Final recommendation issued to sponsor and drug plans | October 04, 2024 |
Final recommendation posted | October 23, 2024 |
Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | October 21, 2024 |
CADTH review report(s) posted | January 30, 2025 |
Call for patient/clinician input open | February 05, 2024 |
---|---|
Call for patient/clinician input closed | April 02, 2024 |
Clarification: - Patient input submission received from The Leukemia and Lymphoma Society of Canada (LLSC) and Heal Canada | |
Submission received | March 19, 2024 |
Submission accepted | April 03, 2024 |
Review initiated | April 04, 2024 |
Draft CADTH review report(s) provided to sponsor for comment | June 21, 2024 |
Deadline for sponsors comments | July 03, 2024 |
CADTH review report(s) and responses to comments provided to sponsor | August 01, 2024 |
Expert committee meeting (initial) | August 14, 2024 |
Draft recommendation issued to sponsor | August 28, 2024 |
Draft recommendation posted for stakeholder feedback | September 05, 2024 |
End of feedback period | September 19, 2024 |
Final recommendation issued to sponsor and drug plans | October 04, 2024 |
Final recommendation posted | October 23, 2024 |
Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | October 21, 2024 |
CADTH review report(s) posted | January 21, 2025 |
Call for patient/clinician input open | 05-Feb-24 |
---|---|
Request for Advice received | 29-Jan-24 |
Manufacturer informed of request for advice | 31-Jan-24 |
Manufacturer information or comments due | 14-Feb-24 |
Request for Advice initiated | 15-Feb-24 |
Call for patient/clinician input closed | 02-Apr-24 |
Clarification: - Patient input submission received from the Gastrointestinal Society | |
Draft Canada's Drug Agency review report(s) sent to sponsor | 16-Apr-24 |
Deadline for sponsors comments | 25-Apr-24 |
Expert committee meeting (initial) | 26-Jun-24 |
Clarification: Project was withdrawn without issuing a revised recommendation |
Call for patient/clinician input open | January 29, 2024 |
---|---|
Call for patient/clinician input closed | March 25, 2024 |
Clarification: - Patient input submission received from Acne and Rosacea Society of Canada (ARSC) and Canadian Skin Patient Alliance (CSPA) | |
Submission received | March 08, 2024 |
Submission accepted | March 26, 2024 |
Clarification: - Submission was not accepted for review on 25 Mar 2024 | |
Review initiated | March 27, 2024 |
Draft CADTH review report(s) provided to sponsor for comment | June 20, 2024 |
Deadline for sponsors comments | July 03, 2024 |
CADTH review report(s) and responses to comments provided to sponsor | August 16, 2024 |
Expert committee meeting (initial) | August 28, 2024 |
Draft recommendation issued to sponsor | September 11, 2024 |
Draft recommendation posted for stakeholder feedback | September 19, 2024 |
End of feedback period | October 04, 2024 |
Final recommendation issued to sponsor and drug plans | October 18, 2024 |
Final recommendation posted | November 05, 2024 |
Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | November 01, 2024 |
CADTH review report(s) posted | February 21, 2025 |
Call for patient/clinician input open | 22-Jan-24 |
---|---|
Call for patient/clinician input closed | 19-Mar-24 |
Clarification: - Patient input submission received from Cystic Fibrosis Canada | |
Submission received | 05-Mar-24 |
Submission accepted | 20-Mar-24 |
Review initiated | 21-Mar-24 |
Draft CADTH review report(s) provided to sponsor for comment | 06-Jun-24 |
Deadline for sponsors comments | 17-Jun-24 |
CDA-AMC review report(s) and responses to comments provided to sponsor | 16-Aug-24 |
Expert committee meeting (initial) | 28-Aug-24 |
Draft recommendation issued to sponsor | 10-Sep-24 |
Draft recommendation posted for stakeholder feedback | 19-Sep-24 |
End of feedback period | 04-Oct-24 |
Final recommendation issued to sponsor and drug plans | 17-Oct-24 |
Final recommendation posted | 04-Nov-24 |
Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | 31-Oct-24 |
CDA-AMC review report(s) posted | 17-Mar-25 |
Call for patient/clinician input open | 22-Jan-24 |
---|---|
Call for patient/clinician input closed | 19-Mar-24 |
Clarification: - Patient input submission received from Canadian Alopecia Areata Foundation | |
Submission received | 04-Mar-24 |
Submission accepted | 19-Mar-24 |
Review initiated | 20-Mar-24 |
Draft CADTH review report(s) provided to sponsor for comment | 07-Jun-24 |
Deadline for sponsors comments | 18-Jun-24 |
CADTH review report(s) and responses to comments provided to sponsor | 12-Jul-24 |
Expert committee meeting (initial) | 24-Jul-24 |
Draft recommendation issued to sponsor | 07-Aug-24 |
Draft recommendation posted for stakeholder feedback | 15-Aug-24 |
End of feedback period | 29-Aug-24 |
Final recommendation issued to sponsor and drug plans | 13-Sep-24 |
Final recommendation posted | 02-Oct-24 |
Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | 27-Sep-24 |
CADTH review report(s) posted | 07-Feb-25 |
Review Type: Rapid
Provisional Funding Algorithm |
|
---|---|
Draft Report Posted: | 18-Jan-2024 |
Stakeholder Feedback Deadline: | 25-Jan-2024 |
Final Report Posted: | 21-Mar-2024 |